|
HS Code |
928869 |
| name | Acetohexamide |
| chemical_formula | C15H20N2O4S |
| molecular_weight | 324.4 g/mol |
| drug_class | Sulfonylurea |
| mechanism_of_action | Stimulates insulin release from pancreatic beta cells |
| CAS_number | 968-81-0 |
| appearance | White to off-white crystalline powder |
| solubility | Slightly soluble in water |
| route_of_administration | Oral |
| indication | Type 2 diabetes mellitus |
| brand_name | Dymelor |
| half_life | Around 6-8 hours |
| storage_conditions | Store at room temperature, away from light and moisture |
| side_effects | Hypoglycemia, nausea, skin rash |
| ATC_code | A10BB03 |
As an accredited Acetohexamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Acetohexamide is packaged in a 25g amber glass bottle with a secure screw cap, labeled with hazard warnings and product details. |
| Shipping | Acetohexamide should be shipped in a tightly sealed, labeled container, protected from light and moisture. It must comply with all local, state, and federal regulations for shipping chemicals. Use appropriate secondary containment and cushioning to prevent breakage. Shipping personnel should follow all safety protocols for handling pharmaceutical and laboratory chemicals. |
| Storage | Acetohexamide should be stored in a tightly closed container, away from incompatible substances such as oxidizing agents. Keep it in a cool, dry, and well-ventilated area, protected from moisture and direct sunlight. Avoid exposure to heat and sources of ignition. Proper storage helps prevent degradation and ensures the stability and safety of the chemical. |
Applications of Acetohexamide in Industrial ManufacturingAs the original manufacturer specializing in Acetohexamide, we supply to regulated sectors with a focus on pharmaceutical intermediates and downstream formulation. The following sections outline primary applications where Acetohexamide is established as an essential input, detailing exactation on compliance, process integration, and expected product classes. 1. Oral Antidiabetic Drug Formulation (Sulfonylurea Class)Acetohexamide remains a key active ingredient in the production of first-generation sulfonylurea oral antidiabetic tablets, used primarily for the management of type 2 diabetes mellitus. Finished dosage manufacturers source pharmaceutical grade material to support direct API usage under stringent regulatory oversight, with close attention to batch consistency, impurity control and traceability. Downstream blending with excipients, granulation, and compression into solid tablets require controlled process integration to preserve compound stability and assure release characteristics for patient safety and therapeutic value. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Synthesis of Sulfonylurea Derivatives for API ResearchProcess development facilities and R&D divisions employ Acetohexamide in custom synthesis routes to prepare novel sulfonylurea analogs and related pharmacologically active compounds. Its role as a starting material or reference standard supports exploration of structural-activity relationships, impurity pathway elucidation, and impurity reference generation for regulatory filings. Batch purity and analytical characterization must conform to current compendial and ICH guidelines to support valid downstream research or regulatory submission. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Sourcing for Pharmacopoeia Quality Control Reference StandardsMajor pharmacopoeial organizations and contract analytical laboratories utilize high-purity lots of Acetohexamide as a standard for assay calibration, system suitability testing, and impurity determination in official monographs for quality control labs globally. These batches must meet strict compendial requirements for purity, assay, spectral identity, and impurity thresholds. They underpin daily release testing and regulatory submission of antidiabetic products, necessitating detailed batch documentation and stability studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. API Impurity Marker Synthesis and ProfilingControlled synthesis and supply of trace impurity markers derived from Acetohexamide enable finished dose manufacturers and API suppliers to comply with global impurity identification requirements. Laboratories synthesize and characterize known and unknown impurities for use in spike and recovery, method validation, and stability studies, ensuring thorough impurity control aligned with marketing authorization expectations in regulated pharmaceutical markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Acetohexamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working at the foundation of the chemical manufacturing process gives us a unique perspective on Acetohexamide, a compound developed first and foremost for its solid role in diabetes management. Our facility has been refining the process of Acetohexamide synthesis for decades. Every batch starts in carefully monitored reactors. Experienced chemists, some of whom have spent their careers improving yields and purity thresholds, oversee operations from raw material qualification all the way through post-synthesis quality testing.
Acetohexamide (CAS 968-81-0), known by its systematic name 1-(hexahydro-1H-azepin-1-yl)-3-(p-acetylphenyl)sulfonylurea, is one of the first-generation sulfonylureas, used to help lower blood glucose by stimulating pancreatic beta cells to secrete insulin. What we make here is the actual crystalline powder, not some blend or solution, so our customers receive the pure product for research, further formulation, or pharmaceutical development. Handling the entire production on-site gives us the freedom to keep extremely tight reins on quality. Each lot is tested by HPLC and NMR to guarantee the active ingredient content sits above 99 percent, and we review solubility profiles with each cycle. This isn’t theoretical for us: the purity of the product affects everything downstream. Customers relying on our Acetohexamide for tightly regulated industries can’t risk surprises. We set our minimum assay at 99 percent so those surprises never manifest.
It’s worth noting that sulfonylureas as a class have subtle chemical differences that hugely impact their use and performance. Acetohexamide, as a cyclohexyl-based derivative, enters oral formulations as a blood-glucose lowering agent. There are newer agents now, but Acetohexamide offers a well-defined pharmacokinetic curve for those undertaking comparative studies or for generic pharmaceutical development. From a manufacturing perspective, its synthesis chain involves multi-step sulfonation, condensation, and urea coupling. Each step comes with its own risks and requirements — solvent management, temperature controls, crystallization rate, rinse cycles to remove unreacted starting materials. Over the years, we’ve made small tweaks that add up: switching to high-purity cyclohexyl intermediates not only improves yield but also minimizes any residual organic bases, which, based on our internal data trends, tend to be the troublemakers for impurity spikes if left unchecked.
Controlling for particle size also represents a big part of what sets factory-grade Acetohexamide apart. In research and in process-scale drug production, particle size ties directly to bioavailability and formulation success. Sourcing Acetohexamide from the original manufacturing line means receiving crystals milled by professionals who built the process. Our standard offering sits in the 40–80 micron range, but we have adapted micronization equipment for partners who require a tighter cut. Small shifts in moisture readings get corrected in the blending room, where humidity and temperature stay locked at optimal settings. Product flows directly from synthesis to QA within hours, no unnecessary storage or transit time, which cuts down on degradants that sometimes show up in warehouse-aged stock from less-direct supply chains.
On paper, Acetohexamide specifications sound simple: high assay, low loss on drying, a white or nearly white crystalline appearance, with low levels of related substances. But staying in spec batch after batch demands living with the process daily. The distinctive odor, the way the powder clings to utensils, even the subtle color shifts that indicate the thermal step went just right — these details matter and come only with daily engagement.
We publish certificates of analysis for every lot, with spectral overlays going back years. If a customer from a regulated market inquires about the sodium content, we pull up historical ICP-OES data, not just the last batch. We document throughput time for each production run — our team cares less for theoretical maximums and more for actual, repeatable reliability. Factory direct means any question about history, handling, or variability comes with real data. Testing for trace metals and residual solvents stays current with ICH and USP guidelines, and we shift analytical methods the moment regulations or technology offer a clearer path. Direct access means better insight into the product’s journey and fitness for further use, from pharmaceutical pressing to long-term stability studies.
Sometimes, buyers ask us to compare Acetohexamide to modern sulfonylureas like glibenclamide or gliclazide. Having handled these products in the same facility, the differences go well beyond chemistry. Newer molecules often bring higher potency or altered half-lives, but Acetohexamide stands tall for its consistency and the breadth of its research base. Synthesizing Acetohexamide is less about maximizing active moiety per microgram, and more about trust in the process and the dataset built over decades of use and review.
For pharmaceutical partners, using an older drug molecule has distinct advantages: regulatory familiarity, clinical predictability, and a demonstrated safety profile built in part from real-world surveillance. From the factory angle, the tools and controls for Acetohexamide are time-tested. Unlike other sulfonylureas that demand costly, specialized reagents or rare solvents, we use feedstocks that don’t swing as wildly in price or require continuous new vendor qualification. This streamlines cost and reduces the risk of discontinuities — practical matters that matter once the paperwork moves from the research phase to actual tablet pressing or capsule filling.
Most orders for Acetohexamide go to pharmaceutical manufacturers preparing for generic launches, clinical trials, or academic researchers running comparative efficacy tests. Some veterinary clients use it for small-mammal diabetes research. We do not blend, sweeten, or premix; our shipments consist only of pure, specification-matched crystalline Acetohexamide. Loading docks see pallet after pallet of carefully packed, humidity-controlled bottles leave for direct delivery, where we know the research team receiving our material can dial up our technician and ask about a specific lot’s humidity or how a subtle analytical peak was interpreted.
Our facilities operate not as a warehouse but as a living production line, with batch numbers tracing to real-time manufacturing logs. Shipment always follows QC supervisor sign-off — this has meant the occasional hold if a parameter gets flagged, but this rigor pays off by saving customers time and money. Lost batches don’t leave the facility; QC failures get investigated, not brushed over. The line between manufacturer and customer blurs when feedback comes directly to technical staff — we modify particle size or crystallization time to fit precise end-use requirements: for example, reformulating for improved tableting, or tailoring batch size to mitigate waste in smaller studies. Direct calls from formulation chemists give us the insight to evolve, because being at the source gives us the best vantage point for improvement.
From the factory floor, the key to premium Acetohexamide stays grounded in physical control — vigilance against microcontamination, steadfast observation during temperature ramps, and using the purest solvents available for every wash step. Environmental controls run 24/7, with sensors across production suites. Each step undergoes regular inspection by veteran operators. These employees — many of whom have built years of expertise on the line — know not to rely solely on instruments but to back up every run with observation and team discussion.
Pulling from experience, we see that the questions that matter most come from customers’ concerns: Will my dosed tablets dissolve at the right rate? Will the powder resist caking in humid storage? Has the process changed from last time? Our responsibility means not just compliance but proactive communication. Routine audits from partners and regulatory agencies are not a formality here, but challenges we embrace as opportunities to verify every aspect of our quality mindset. This readiness feeds back into training for newer personnel, encouraging a culture where everyone, not just management, owns product quality.
Working directly with end customers helps us pinpoint shifts in international regulations or shifts in preferred reference standards. Each regulatory landscape adds its own layer to documentation and testing, which our quality division tracks daily. We don’t pack Acetohexamide using a one-size-fits-all approach; different countries, different industries, different batch sizes — all are part of life in a real factory. Our regulatory affairs officers work out of the same building as our chemists, allowing instant communication when customs, testing, or a new market’s launch triggers a documentation review. All paperwork, all the time — our least favorite part, but the one that proves the process is under control.
Producing Acetohexamide safely and responsibly takes serious attention to environmental controls. Sulfonylurea synthesis involves handling hazardous wastes and solvents, including chlorinated intermediates. From inside the plant, it means regular solvent recovery cycles, closed-system filtration, and immediate neutralization of spent reagents. Every kilogram of product carries an equal weight of tracking for generated waste, with disposal meticulously carried out under national and international guidelines.
We invested in dedicated effluent treatment tanks, and updated our emissions abatement equipment to reduce volatile discharge below national thresholds. Community and regulatory pressure prompted us to go beyond the legal minimum, convincing us to keep every process as closed-loop as possible. Energy management receives similar care, with heat exchangers capturing as much process energy as possible for reintegration into the heating system. Emissions and discharge readings get posted for internal review, and suggestions that cut even a percent of waste are implemented following group discussion.
Experience shows that regulatory pressure isn’t the only driver for cleaner production. Listening to visiting scientists and purchasing managers concerned about their downstream impact has pushed us to phase in greener process aids and target energy use for further reduction. Every time we install a better scrubber or switch to a water-based cleaning agent, it reflects real feedback, not just compliance with paperwork. Our operators, many with a personal commitment to responsible stewardship, help us spot inefficiencies and cut the risks of accidental release at every point.
Handling Acetohexamide calls for careful control of temperature and humidity, starting from the end of synthesis to the moment it passes into tightly sealed bottles. Our operators pack every order in multilayer, light-proof containers — packaging meant to keep out both water vapor and light. Packing happens within hours of QA clearance, because Acetohexamide, like many sulfonylureas, can slowly degrade with long-term exposure to the wrong climate. Direct-from-factory logistics skip middleman warehouses, which further minimizes time in uncontrolled transit, reducing the chance of hydrolysis before delivery.
All labels carry complete batch number tracing and storage recommendations, drawn from our in-house stability data. Should customers have a question about whether storage below a certain temperature affects potency, we share not just a generic answer but records from real accelerated aging tests on actual product, not extrapolations. Our technical group keeps open lines of discussion for field reports, adjusting documentation or advice based on the latest reports from customer warehouses or logistics partners.
From the plant, direct communication fixes far more problems than prescriptive policies. Should a customer call about caking or suspected degradation, our support team responds with practical, experiment-driven troubleshooting, often sending real samples and fresh analytical data drawn from retained reference specimens. We keep a reserve of each batch for reference exactly for such scenarios, so we can test old material under new conditions and solve field problems based on what our real product has done, not just theoretical stability estimations.
Factory-direct procurement is more than a business slogan for Acetohexamide, especially as trust and traceability become essential in an era of global supply chains. Counterfeit or degraded material from poorly documented suppliers risks failure not just in laboratory tests, but in human health. Transparent records — from raw material origin, supplier audits, to test logs — travel with every bottle shipped from our facility. Our customers have direct access to chemists and production managers, not just sales representatives reading from a script.
Over the years, shipment delays due to customs, port congestion, or regulatory review have taught us to keep enough buffer stock on hand so nobody waits unnecessarily for critical material. This stands as a distinguishing feature: actual manufacturers can respond to sudden spikes in demand or unexpected shortages with agility, because our entire supply chain is visible from our analysts' desks. Years of direct relationships with shipping agents and customs brokers means product spends less time in limbo, reducing the risk of temperature excursions or loss.
Our experience reinforces a simple lesson: confidence in the end product reflects confidence in the process and the people producing it. Every label, every shipment, every bottle of Acetohexamide carries the reputations of all factory workers and supervision with it, which is why the origin and quality controls stand open to scrutiny. If an issue arises, we are not intermediaries sending replacement stock from a warehouse; we are the source, the ones who get on the phone with regulatory bodies, trace the production log, and offer real solutions.
Our time producing Acetohexamide has proven that product knowledge goes far beyond technical sheets and regulatory paperwork. Every improvement in process — from minor tweaks in raw material sourcing to shifts in solvent selection — reflects lessons learned directly from production, not handed down from distant R&D or a corporate office. It’s not just about meeting pharmacopeial standards, but about pushing product quality and stability further because the same people who make the product hear directly from the people using it.
Connections with academia and leading pharmaceutical laboratories mean that new details about solubility, interaction, or new application goals filter straight into our production review. Batch failures never vanish into statistics; each gets scrutinized, retested, the root cause analyzed so future lots incorporate fixes right away. This relentless approach to refinement means even an established molecule like Acetohexamide continues to see progress in particle dynamic control, waste handling, and downstream application adaptation.
In the end, being a direct manufacturer stands for more than just physical origin — it is a promise of technical accuracy, transparency, and accountability. Our technical staff and line operators stake their work on every decisive test result, each certificate of analysis, and, most importantly, on every user who calls with a question about a bottle’s performance in the field, whether for research, formulation, or pharmaceutical launch. We stand behind Acetohexamide from molecule to market, because, for us, the commitment runs as long as the process does, every step of the way.